Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fluclorolone acetonide is a potent synthetic glucocorticoid corticosteroid primarily used for its anti-inflammatory and immunosuppressive properties in dermatological applications. It exerts its therapeutic effects by penetrating cellular membranes and binding to specific glucocorticoid receptors in the cytoplasm. This drug-receptor complex then translocates to the nucleus, where it modulates gene transcription, leading to the suppression of pro-inflammatory molecules such as cytokines, prostaglandins, and leukotrienes, and reducing immune cell activity. It also stabilizes lysosomal membranes, preventing the release of enzymes that contribute to tissue destruction, thereby reducing swelling, redness, and pain associated with inflammatory skin conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fluclorolone acetonide.